AbbVie Inc (ABBV)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$222.50
Buy
$224.34
$-0.66 (-0.29%)
Prices updated at 13 Dec 2025, 00:42 EST
| Prices minimum 15 mins delay
Prices in USD
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 69.99 |
| 2023 | 62.42 |
| 2022 | 70.00 |
| 2021 | 68.96 |
| 2020 | 66.41 |
| 2019 | 77.64 |
| 2018 | 76.44 |
| 2017 | 75.04 |
| 2016 | 77.25 |
| 2015 | 80.31 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 6.64 |
| 2024 | 5.67 |
| 2023 | 4.99 |
| 2022 | 4.97 |
| 2021 | 4.36 |
| 2020 | 4.22 |
| 2019 | 4.01 |
| 2018 | 4.50 |
| 2017 | 5.70 |
| 2016 | 4.06 |
| 2015 | 4.41 |
Price/Forward earnings (YTD)
15.90
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 3.14 |
| 2023 | 3.52 |
| 2022 | 8.26 |
| 2021 | 7.72 |
| 2020 | 3.80 |
| 2019 | 10.56 |
| 2018 | 8.69 |
| 2017 | 7.72 |
| 2016 | 9.94 |
| 2015 | 12.71 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 40.65 |
| 2023 | 13.00 |
| 2022 | 8.04 |
| 2021 | 9.51 |
| 2020 | 11.51 |
| 2019 | - |
| 2018 | - |
| 2017 | 13.89 |
| 2016 | 14.26 |
| 2015 | 13.45 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
